Earnings History Data for Addex Therapeutics Ltd (ADXN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include GABAB PAM for CMT1A, mGlu7 NAM for PTSD, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson's disease and mGlu3 PAM for neurodegenerative disorders. GABAB PAM program has been licensed to Indivior PLC for the treatment of addiction. Addex Therapeutics Ltd is based in Geneva, Switzerland.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-09-2024 | PM | ADXN | Addex Therapeutics | 10.00 | -1.77 | -0.07 | 0.00 | Addex Therapeutics GAAP EPS of CHF0.08, revenue of CHF0.12M [9/30/2024 4:10 AM] |
9.65 | 0.60 (6.63%) |
9.95 | 0.90 (9.94%) |
5.00 - 27.90 | 11,121 | 40,000 | 1,906 | ||
| 06-06-2024 | PM | ADXN | Addex Therapeutics Ltd | 9.48 | -1.37 | 0.00 | -5.20 | Addex Therapeutics GAAP EPS of -CHF 0.01, revenue of CHF 0.24M [6/6/2024 1:28 AM] |
9.20 | 0.21 (2.34%) |
0.0 | 0.0 (0.00%) |
5.00 - 27.90 | 2,335 | 0 | 0 | ||
| 29-11-2023 | PM | ADXN | Addex Therapeutics Ltd | 4.55 | -4.07 | 4.00 | -11.20 | Addex Therapeutics GAAP EPS of -CHF0.03, income of CHF0.33M [11/29/2023 1:31 AM] |
5.71 | 0.01 (0.26%) |
0.0 | 0.0 (0.00%) |
5.10 - 45.60 | 3,486 | 10,000 | 0 | ||
| 10-08-2023 | PM | ADXN | Addex Therapeutics Ltd | 6.90 | -0.25 | 0.00 | -1.18 | Addex Therapeutics GAAP EPS of -CHF 0.04 [8/10/2023 1:22 AM] |
0.5599 | 0.0 (0.16%) |
0.56 | 0.0 (0.20%) |
0.42 - 2.28 | 41,112 | 50,000 | 2,948 | ||
| 11-05-2023 | PM | After the close (May 11) |
ADXN | Addex Therapeutics Ltd | 11.06 | -0.26 | 0.00 | -0.97 | Addex Therapeutics GAAP EPS of -CHF0.04 [5/11/2023 5:57 AM] |
0.88 | -0.06 (-6.65%) |
0.82 | -0.12 (-12.49%) |
0.55 - 4.34 | 766,897 | 1,650,000 | 147,693 | |
| 30-03-2023 | PM | 1:00 AM ET (Mar 30) |
ADXN | Addex Therapeutics Ltd | 40.37 | -0.25 | 0.00 | -0.83 | Addex Therapeutics GAAP EPS of -CHF 0.46 [3/30/2023 1:38 AM] |
0.97 | -0.16 (-14.16%) |
1.16 | 0.03 (2.65%) |
0.55 - 5.45 | 240,328 | 110,000 | 3,789 | |
| 11-11-2022 | PM | 1:00 AM ET (Nov 11) |
ADXN | Addex Therapeutics Ltd | 7.78 | -0.56 | -0.56 | -0.72 | Addex Therapeutics GAAP EPS of -CHF0.09, revenue of CHF0.42M [11/11/2022 1:35 AM] |
0.7653 | 0.0 (-0.21%) |
0.81 | 0.04 (5.44%) |
0.64 - 8.04 | 1,198,066 | 90,000 | 12,215 | |
| 18-08-2022 | PM | 1:00 AM ET (Aug 18) |
ADXN | Addex Therapeutics Ltd | 12.50 | -1.18 | -0.56 | -0.77 | Addex Therapeutics GAAP EPS of -CHF 0.19 [8/18/2022 1:39 AM] |
1.33 | 0.04 (3.10%) |
1.33 | 0.04 (3.10%) |
0.86 - 10.28 | 654,090 | 540,000 | 6,051 | |
| 05-05-2022 | PM | ADXN | Addex Therapeutics Ltd | 30.13 | -0.97 | -0.52 | -0.53 | Addex Therapeutics GAAP EPS of -CHF 0.15 [5/5/2022 1:51 AM] |
4.93 | 0.46 (10.17%) |
0.0 | 0.0 (0.00%) |
4.06 - 11.48 | 4,027 | 2,932 | 0 | ||
| 10-03-2022 | PM | 2:00 AM ET (Mar 10) |
ADXN | Addex Therapeutics Ltd | 31.14 | -0.83 | -0.66 | -0.53 | Addex Therapeutics GAAP EPS of -CHF 0.45 [3/10/2022 1:33 AM] |
5.01 | 0.15 (3.09%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 98 | 0 | 0 | |
| 04-11-2021 | PM | 1:00 AM ET (Nov 4) |
ADXN | Addex Therapeutics Ltd | 44.75 | -0.72 | -0.72 | -0.78 | Addex Therapeutics reports Q3 results [11/4/2021 2:21 AM] |
8.50 | 0.57 (7.19%) |
8.33 | 0.40 (5.04%) |
7.51 - 35.00 | 898 | 0 | 1,400 | |
| 05-08-2021 | PM | 1:00 AM ET (Aug 5) |
ADXN | Addex Therapeutics Ltd | 71.35 | -0.77 | -0.65 | -0.75 | Addex Therapeutics reports Q2 results [8/5/2021 1:58 AM] |
9.85 | 0.01 (0.05%) |
0.0 | 0.0 (0.00%) |
8.88 - 37.52 | 1,214 | 0 | 0 | |
| 05-05-2021 | PM | 1:00 AM ET (May 5) |
ADXN | Addex Therapeutics Ltd | 71.03 | -0.53 | -0.65 | -0.99 | Addex Therapeutics reports Q1 results [5/5/2021 2:06 AM] |
9.81 | 0.07 (0.72%) |
0.0 | 0.0 (0.00%) |
7.00 - 37.52 | 1,556 | 10,000 | 0 | |